About SIRAKOSS
SIRAKOSS is a company based in Aberdeen (United Kingdom) founded in 2010 was acquired by OssDsign in November 2020.. SIRAKOSS has raised $4.8 million across 3 funding rounds from investors including Gov.uk, OssDsign and Scottish Enterprise. SIRAKOSS offers products and services including OssDsign Catalyst. SIRAKOSS operates in a competitive market with competitors including Theradaptive, MiMedx Group, Ossio, RevBio and Aziyo Biologics, among others.
- Headquarter Aberdeen, United Kingdom
-
Sectors
Healthcare
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Ossdsign Ab
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of SIRAKOSS
SIRAKOSS offers a comprehensive portfolio of products and services, including OssDsign Catalyst. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Nanosynthetic graft for rapid bone formation in surgical fusions.
Funding Insights of SIRAKOSS
SIRAKOSS has successfully raised a total of $4.8M across 3 strategic funding rounds. The most recent funding activity was a Grant round of $226.83 thousand completed in July 2016. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 3
- Last Round Grant — $226,825
-
First Round
First Round
(02 Dec 2014)
- Investors Count 4
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2016 | Amount | Grant - SIRAKOSS | Valuation |
investors |
|
| Dec, 2014 | Amount | Grant - SIRAKOSS | Valuation |
investors |
|
| Dec, 2014 | Amount | Series A - SIRAKOSS | Valuation |
investors |
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in SIRAKOSS
SIRAKOSS has secured backing from 5 investors, including institutional and venture fund investors. Prominent investors backing the company include Gov.uk, OssDsign and Scottish Enterprise. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
-
|
Founded Year | Domain | Location | |
|
Online government services and information are provided to users.
|
Founded Year | Domain | Location | |
|
Business development and leadership training programs are offered to companies.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by SIRAKOSS
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - SIRAKOSS
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Sirakoss Comparisons
Competitors of SIRAKOSS
SIRAKOSS operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Theradaptive, MiMedx Group, Ossio, RevBio and Aziyo Biologics, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Therapeutic delivery platform is developed for orthopedic clinical indications.
|
|
| domain | founded_year | HQ Location |
Regenerative biomaterial products and bioimplants for wound, surgical, sports medicine and orthopedics
|
|
| domain | founded_year | HQ Location |
Orthopedic fixation is enabled by bone regeneration biocomposite technology.
|
|
| domain | founded_year | HQ Location |
Synthetic adhesives for bone and dental repair are developed.
|
|
| domain | founded_year | HQ Location |
Regenerative medicine products are developed for orthopedic and cardiovascular applications.
|
|
| domain | founded_year | HQ Location |
Developer of stem cells to regrow damaged bones
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Sirakoss
Frequently Asked Questions about SIRAKOSS
When was SIRAKOSS founded?
SIRAKOSS was founded in 2010 and raised its 1st funding round 4 years after it was founded.
Where is SIRAKOSS located?
SIRAKOSS is headquartered in Aberdeen, United Kingdom. It is registered at Aberdeen, Scotland, United Kingdom.
Is SIRAKOSS a funded company?
SIRAKOSS is a funded company, having raised a total of $4.8M across 3 funding rounds to date. The company's 1st funding round was a Grant of $1.47M, raised on Dec 02, 2014.
What does SIRAKOSS do?
SIRAKOSS was founded in 2010 as a spin-out from the University of Aberdeen and is based in Aberdeen City, Scotland. The company operates in the medical device sector, focusing on synthetic bone graft substitutes for treating bone defects and fusions in trauma and spinal applications. Its portfolio features MaxSi graft granules in standard sizes and MaxSi graft putty, which can be reshaped, with performance validated in pre-clinical models.
Who are the top competitors of SIRAKOSS?
SIRAKOSS's top competitors include EpiBone, Theradaptive and MiMedx Group.
What products or services does SIRAKOSS offer?
SIRAKOSS offers OssDsign Catalyst.
Who are SIRAKOSS's investors?
SIRAKOSS has 5 investors. Key investors include Gov.uk, OssDsign, Scottish Enterprise, Epidarex Capital, and Armourers' Hall.
Book a demo & talk to our team
Share a few details and we’ll reach out to schedule a session.